Exclusive

Publication

Byline

Location

T-Mobile Unveils Starlink Beta To Deliver Mobile Connectivity In Remote Areas Using Satellite Tech

India, Feb. 9 -- T-Mobile has officially launched the beta version of its Starlink service. This service aims to provide mobile connectivity in areas where traditional cell towers cannot reach, using ... Read More


Australia Building Consents Rise 0.7% In December

India, Feb. 9 -- The total number of building permits issued in Australia was up a seasonally adjusted 0.7 percent on month in December, the Australian Bureau of Statistics said on Monday - coming in ... Read More


Japan Overall Bank Lending Climbs 3.0% On Year In January

India, Feb. 9 -- Overall bank lending in Japan was up 3.0 percent on year in January, the Bank of Japan said on Monday - coming in at 635.707 trillion yen. That's unchanged from the December reading ... Read More


Japan Has Y1.077 Trillion Current Account Surplus

India, Feb. 9 -- Japan posted a current account surplus of 1.077 trillion yen in December, the Ministry of Finance said on Monday - up 17.8 percent on year. It was, however, shy of expectations for a... Read More


Munters To Divest FoodTech Equipment Offering To Grain & Protein Technologies For EUR 97.5 Mln

India, Feb. 9 -- Munters Group AB announced that it has agreed to sell FoodTech Equipment offering to Grain & Protein Technologies (GPT), owned by American Industrial Partners (AIP), for EUR 97.5 mill... Read More


4D Molecular Therapeutics Reports Positive Interim Data From Phase 2b Trial For Wet AMD

India, Feb. 8 -- 4D Molecular Therapeutics (FDMT) announced positive initial interim 52-week data from the Phase 2b Population Extension cohort of the PRISM clinical trial evaluating 4D-150 in a broad... Read More


Regeneron Announces Positive Phase 3 Results For EYLEA HD In Retinal Vein Occlusion Treatment

India, Feb. 8 -- Regeneron Pharmaceuticals Inc. (REGN) announced encouraging outcomes from the Phase 3 QUASAR trial, which evaluated the efficacy of EYLEA HD (aflibercept) Injection 8 mg for treating ... Read More


Regeneron : EYLEA HD Shows Sustained Vision Gains In Wet AMD Patients At 3 Years

India, Feb. 8 -- Regeneron Pharmaceuticals Inc. (REGN) announced positive three-year (156-week) results for EYLEA HD (aflibercept) Injection 8 mg in patients with wet age-related macular degeneration ... Read More


Boeing Reportedly Plans To Lay Off About 400 Employees From Space Launch System Program

India, Feb. 8 -- Boeing Co. (BA) is planning to lay off approximately 400 employees from its Space Launch System (SLS) program due to changes in NASA's Artemis program and evolving cost projections, a... Read More


KeyMed Biosciences' Stapokibart Approved In China For Seasonal Allergic Rhinitis Treatment

India, Feb. 8 -- KeyMed Biosciences announced that the National Medical Products Administration of China has approved the supplemental New Drug Application of Stapokibart (anti-IL-4Ra monoclonal antib... Read More